Variant report

Variant	esv1841903
Chromosome Location	chr6:167459596-167489090
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:8)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:8 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr6:167487932..167489942-chr6:167492963..167495055,2	K562	blood:
2	chr6:167200327..167200836-chr6:167459295..167459843,2	K562	blood:
3	chr6:167188018..167188945-chr6:167458801..167459761,3	MCF-7	breast:
4	chr6:167454169..167455868-chr6:167473255..167476211,2	K562	blood:
5	chr6:167433511..167435298-chr6:167462855..167465719,2	K562	blood:
6	chr6:167453011..167457183-chr6:167458189..167461851,4	K562	blood:
7	chr6:167150380..167152971-chr6:167466714..167468496,2	K562	blood:
8	chr6:167459004..167459905-chr6:167555024..167555917,3	MCF-7	breast:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-FGFR1OP-8	chr6:167465448-167466347	NONHSAT116076

No data

Extended variants
information (count: 650 )
Associated
traits (count: 84 )

Variant overlapped rSNPs/rCNVs (count:650 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs10946208	chr6:167459596-167459597	Weak transcription Strong transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs201851004	chr6:167459692-167459693	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs368257518	chr6:167459694-167459695	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs574246776	chr6:167459739-167459740	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs541742921	chr6:167459770-167459771	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs191307108	chr6:167459771-167459772	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs571366922	chr6:167459795-167459796	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs200153128	chr6:167459797-167459798	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs76839216	chr6:167459808-167459809	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs73035060	chr6:167459828-167459829	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs369611902	chr6:167459847-167459848	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs75687124	chr6:167459983-167459984	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs564254875	chr6:167460005-167460006	Weak transcription Strong transcription ZNF genes & repeats Enhancers Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs200545216	chr6:167460050-167460051	Weak transcription Strong transcription ZNF genes & repeats Enhancers Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs575146718	chr6:167460051-167460052	Weak transcription Strong transcription ZNF genes & repeats Enhancers Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs116318212	chr6:167460092-167460093	Weak transcription Strong transcription ZNF genes & repeats Enhancers Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs114928703	chr6:167460105-167460106	Weak transcription Strong transcription ZNF genes & repeats Enhancers Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs527680540	chr6:167460161-167460162	Weak transcription Strong transcription ZNF genes & repeats Enhancers Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs529472170	chr6:167460193-167460194	Weak transcription Strong transcription ZNF genes & repeats Enhancers Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs551328484	chr6:167460220-167460221	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs569425741	chr6:167460227-167460228	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs375905822	chr6:167460230-167460231	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs186216087	chr6:167460235-167460236	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs554830685	chr6:167460247-167460248	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs189889312	chr6:167460260-167460261	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs555017323	chr6:167460289-167460290	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs112558758	chr6:167460315-167460316	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs566816582	chr6:167460378-167460379	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs377489996	chr6:167460439-167460440	Weak transcription Enhancers Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs34803307	chr6:167460489-167460490	Weak transcription Enhancers Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs111315594	chr6:167460492-167460493	Weak transcription Enhancers Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs182106020	chr6:167460511-167460512	Weak transcription Enhancers Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs534031206	chr6:167460513-167460514	Weak transcription Enhancers Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs372913696	chr6:167460524-167460525	Weak transcription Enhancers Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs6909180	chr6:167460537-167460538	Weak transcription Enhancers Flanking Active TSS Strong transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
36	rs535256535	chr6:167460568-167460569	Weak transcription Enhancers Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs557252036	chr6:167460571-167460572	Weak transcription Enhancers Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs188073162	chr6:167460574-167460575	Weak transcription Enhancers Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs12213683	chr6:167460718-167460719	Weak transcription Enhancers Flanking Active TSS Strong transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
40	rs557480486	chr6:167460729-167460730	Weak transcription Enhancers Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs146335239	chr6:167460734-167460735	Weak transcription Enhancers Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs540353572	chr6:167460765-167460766	Weak transcription Enhancers Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs561747937	chr6:167460772-167460773	Weak transcription Enhancers Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs190992303	chr6:167460773-167460774	Weak transcription Enhancers Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs183576228	chr6:167460798-167460799	Weak transcription Enhancers Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs563234483	chr6:167460817-167460818	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs188571046	chr6:167460868-167460869	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs552002308	chr6:167460880-167460881	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs66772047	chr6:167460889-167460890	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs61515295	chr6:167460892-167460893	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:84)

Disease	PMID	Source
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Biliary cancer	19435499	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Neuroblastoma	18923191	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	19010834	CNVD
Non-small cell lung cancer	21044232	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	16608533	CNVD
Non-small cell lung cancer	21385341	CNVD
Prostate cancer	16705090	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Colorectal cancer	16272173	CNVD
Ependymoma	16718352	CNVD
Gastric cancer	17908304	CNVD
High-proliferative meningiomas	17937814	CNVD
Intracranial tumor	16823260	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	16272173	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Malignant melanoma	18718029	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Breast cancer	21858162	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	17603634	CNVD
Developmental delay	19490664	CNVD
Burkitt''s lymphoma	18698080	CNVD
Neurodevelopmental disorder	22521361	CNVD
small cell lung cancer	20016488	CNVD
Adenoid cystic carcinoma	18698036	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Leukemia	18688285	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Burkitt''s lymphoma	19759907	CNVD
Esophageal cancer	21851588	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Breast cancer	17133270	CNVD
Testicular germ cell tumor	18059402	CNVD
Chordoma	18071362	CNVD
Glioblastoma multiforme	19435819	CNVD
Developmental delay	21147756	CNVD
Ovarian cancer	21720365	CNVD
abnormal development	18461090	CNVD
Epilepsy	22083797	CNVD
Myelofibrosis	22110671	CNVD
chordoma	19801981	CNVD
Myxofibrosarcoma	16751306	CNVD
Autism	17483303	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Acute myeloid leukemia	19651601	CNVD
Sudden cardiac death	19188705	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Acute lymphoblastic leukemia	18458336	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD

Chromatin state (count:298 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:167441000-167461800	Weak transcription	Pancreatic Islets	Pancreatic Islet
2	chr6:167441400-167473400	Weak transcription	Psoas Muscle	Psoas
3	chr6:167445600-167460200	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
4	chr6:167448200-167459800	Weak transcription	iPS-15b Cell Line	embryonic stem cell
5	chr6:167448200-167467200	Weak transcription	HMEC	breast
6	chr6:167448400-167467200	Weak transcription	NHEK	skin
7	chr6:167448800-167460000	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
8	chr6:167449000-167467800	Weak transcription	Skeletal Muscle Male	skeletal muscle
9	chr6:167449000-167470400	Weak transcription	Brain Anterior Caudate	brain
10	chr6:167449800-167459600	Weak transcription	Brain Cingulate Gyrus	brain
11	chr6:167449800-167462800	Weak transcription	Brain Hippocampus Middle	brain
12	chr6:167450000-167460800	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
13	chr6:167450000-167467400	Weak transcription	Ovary	ovary
14	chr6:167450200-167463000	Weak transcription	Brain Germinal Matrix	brain
15	chr6:167450600-167460600	Weak transcription	Primary neutrophils fromperipheralblood	blood
16	chr6:167450600-167463000	Weak transcription	Fetal Brain Female	brain
17	chr6:167451200-167460200	Weak transcription	Placenta	Placenta
18	chr6:167451600-167461600	Weak transcription	Placenta Amnion	Placenta Amnion
19	chr6:167451600-167462000	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
20	chr6:167451600-167463600	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
21	chr6:167451600-167467000	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
22	chr6:167451600-167467400	Weak transcription	Skeletal Muscle Female	skeletal muscle
23	chr6:167451600-167468400	Weak transcription	Esophagus	oesophagus
24	chr6:167452000-167460000	Weak transcription	Stomach Mucosa	stomach
25	chr6:167453800-167460200	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
26	chr6:167454000-167460200	Weak transcription	Fetal Thymus	thymus
27	chr6:167454000-167460200	Weak transcription	Rectal Mucosa Donor 29	rectum
28	chr6:167454000-167463400	Weak transcription	Aorta	Aorta
29	chr6:167454000-167464600	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
30	chr6:167454200-167459600	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
31	chr6:167454200-167459800	Weak transcription	Fetal Lung	lung
32	chr6:167454200-167462600	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
33	chr6:167454400-167461600	Weak transcription	A549	lung
34	chr6:167454400-167463200	Weak transcription	Brain Substantia Nigra	brain
35	chr6:167454600-167464400	Weak transcription	Cortex derived primary cultured neurospheres	brain
36	chr6:167454800-167459800	Strong transcription	Fetal Intestine Small	intestine
37	chr6:167455000-167459800	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
38	chr6:167455000-167462600	Weak transcription	Duodenum Smooth Muscle	Duodenum
39	chr6:167455000-167462800	Weak transcription	HSMM	muscle
40	chr6:167455000-167470600	Weak transcription	Breast Myoepithelial Primary Cells	Breast
41	chr6:167455200-167467600	Weak transcription	Liver	Liver
42	chr6:167455400-167459600	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
43	chr6:167455400-167459800	Weak transcription	Monocytes-CD14+_RO01746	blood
44	chr6:167456000-167460400	Strong transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
45	chr6:167456200-167459600	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
46	chr6:167456200-167460600	Weak transcription	Adipose Nuclei	Adipose
47	chr6:167456200-167467000	Weak transcription	Left Ventricle	heart
48	chr6:167456200-167467400	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
49	chr6:167456200-167468400	Weak transcription	Rectal Mucosa Donor 31	rectum
50	chr6:167456200-167470800	Weak transcription	HUES64 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links